Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016

Overview of attention for article published in JAMA Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 180 X posts from 137 X users, with an upper bound of 1,258,575 followers.

RT @Abdallah81MD: Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Ther…

RT @Abdallah81MD: Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Ther…

RT @Abdallah81MD: Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Ther…

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016 ⁦@JAMAOnc⁩ ⁦@JAMA_current⁩ ⁦@JAMAInternalMed⁩ https://t.co/HyY8HOBd6q

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 176 additional X posts.